Drug Trial Radar · NCT05913752
A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects
Last checked: Nov 19, 2026Latest source record: Mar 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
84
Planned (sponsor's estimate)
Start
Apr 30, 2025
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Clearmind Medicine Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 22, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to find the tolerable dose and characterize the safety and pharmacokinetics/ pharmacodynamics (PK/PD) of single and repeated dose of CMND-100 in Healthy Volunteers (HV) and Subjects with Alcohol Use Disorder (AUD). The secondary objective of this study is to preliminarily evaluate the efficacy of CMND-100 in reduction of drinking patterns and craving in subjects with moderate to severe AUD.
Conditions
- Alcohol Use Disorder
Interventions
CMND-100Drug
The investigational product CMND-100 consists of gelatin capsules, each containing the active ingredient (either 20 or 60 mg) 5-methoxy-2-aminoindane (MEAI) and excipients (stabilizers). MEAI is a psychoactive compound of the aminoindane class
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety as Adverse Events ProfileTime frame: up to 31 days
- TmaxTime frame: up to 31 days
- CmaxTime frame: up to 31 days
- AUC0-∞Time frame: up to 31 days
- t1/2Time frame: up to 31 days
- ClTime frame: up to 31 days
- VdTime frame: up to 31 days
Locations
4 sites in 2 countries. Site status is shown where the registry gives one.
Connecticut Mental Health Center
New Haven, Connecticut · Recruiting
Johns Hopkins Bayview Medical Center
Baltimore, Maryland · Recruiting
Hadassah Medical Center
Jerusalem, Israel · Recruiting
Tel-Aviv Sourasky Medical Center (TASMC)
Tel Aviv, Israel · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.